Status:
COMPLETED
Tumor-Infiltrating Lymphocytes in Endometrial Cancer
Lead Sponsor:
Jagiellonian University
Conditions:
Endometrium Cancer
Tumor Infiltration
Eligibility:
FEMALE
18+ years
Brief Summary
Endometrial cancer (EC) is a leading cancer among women globally. The tumor microenvironment in EC is characterized by complex interactions between cancer cells and immune components. Among these prot...
Detailed Description
The study was conducted using properly stored archival formalin-fixed paraffin-embedded tissue blocks. The inclusion criteria required a confirmed diagnosis of EC, adequate quality of archival materia...
Eligibility Criteria
Inclusion
- confirmed diagnosis of EC
- adequate quality of archival material
- absence of prior neoadjuvant treatment
- complete medical documentation
Exclusion
- none
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 8 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06976333
Start Date
December 1 2024
End Date
May 8 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jagiellonian University
Krakow, Poland